Table 4.
Patient | SOPmax (min) |
SEN (%) |
FPR (/h) |
MIT (min) |
SPE (%) |
PT (%) |
---|---|---|---|---|---|---|
1 | 30 | 100 ± 0 | 0.28 ± 0.03 | 5.7 ± 2.6 | 90.2 ± 1.7 | 8.1 ± 1.3 |
50 | 100 ± 0 | 0.18 ± 0.02 | 48.2 ± 2.5 | |||
| ||||||
2 | 30 | 100 ± 0 | 0 ± 0 | 11.4 ± 0 | 100 ± 0 | 0 ± 0 |
50 | 100 ± 0 | 0 ± 0 | 40.9 ± 2 | |||
| ||||||
3 | 30 | 55 ± 19 | 0.32 ± 0.06 | 26.8 ± 4.6 | 93.2 ± 2.5 | 5.6 ± 2 |
50 | 100 ± 0 | 0.23 ± 0.05 | 40.1 ± 6.4 | |||
| ||||||
4 | 30 | 100 ± 0 | 0 ± 0 | 15.1 ± 5.7 | 100 ± 0 | 0 ± 0 |
50 | 100 ± 0 | 0 ± 0 | 42.9 ± 11 | |||
| ||||||
5 | 30 | 100 ± 0 | 0 ± 0 | 16.8 ± 6.7 | 100 ± 0 | 0 ± 0 |
50 | 100 ± 0 | 0 ± 0 | 48.8 ± 1.5 | |||
| ||||||
6 | 30 | 100 ± 0 | 0.11 ± 0.01 | 28.5 ± 2.4 | 95 ± 0.2 | 8.3 ± 0.2 |
50 | 100 ± 0 | 0.06 ± 0.01 | 49.8 ± 0 | |||
| ||||||
7 | 30 | 100 ± 0 | 0.04 ± 0.04 | 1.9 ± 1.4 | 99.3 ± 1.2 | 0.6 ± 1 |
50 | 100 ± 0 | 0.02 ± 0.02 | 1.9 ± 1.4 | |||
| ||||||
8 | 30 | 67 ± 0 | 0.11 ± 0.03 | 1 ± 0.5 | 98.1 ± 0.7 | 1.6 ± 0.6 |
50 | 67 ± 0 | 0.11 ± 0.03 | 1 ± 0.5 | |||
| ||||||
9 | 30 | 100 ± 0 | 0.13 ± 0.07 | 18.4 ± 2.8 | 98.5 ± 1.3 | 1.3 ± 1.1 |
50 | 100 ± 0 | 0.11 ± 0.04 | 18.9 ± 2.5 | |||
| ||||||
10 | 30 | 45 ± 8 | 0.27 ± 0.1 | 17.7 ± 7 | 93.3 ± 3.7 | 5.6 ± 3 |
50 | 63 ± 13 | 0.24 ± 0.09 | 40.6 ± 10.8 | |||
| ||||||
Grand Average | 30 | 86.7 ± 18.9 | 0.126 ± 0.11 | 14.3 ± 9 | 96.7 ± 3.2 | 3.8 ± 3.8 |
50 | 92.9 ± 11.3 | 0.096 ± 0.085 | 33.3 ± 17.1 |
Mean and absolute deviation (AD) over the performance parameters obtained using the ten reference windows randomly selected for each patient. Results are rounded and expressed as mean ± AD. SOPmax: maximum seizure occurrence period; SEN: sensitivity; SPE: specificity; FPR: false prediction rate; PT: portion of time under false predictions; MPT: Mean prediction time.